With a strong reputation for achieving enrolment targets, collecting high-quality data, and providing superior patient care, Dermatology Research Institute is recognized regionally, nationally, and globally as a respected leader in clinical and epidemiological trials.
73
Studies
546
Patients Enrolled
8686
Patient-Years of Data
We are well-versed in many different types of studies, ranging from pediatric to adult, phase II to IV, observational to interventional, and short to long duration.
Through meaningful collaboration with major pharmaceutical companies from around the globe, Dermatology Research Institute has the privilege of investigating the latest emerging treatments for a variety of diseases that patients suffer from.
29
Different Industry Sponsors
9
Different Diseases Investigated
33
Different Treatments Investigated
We focus on and have an expertise in studying targeted treatments for immune-mediated inflammatory diseases.
With frequent authorship in impactful publications and presentations, Dermatology Research Institute is at the forefront of disseminating and communicating scientific advances to other healthcare professionals, patients, and the public.
12
Peer-Reviewed Publications in
Scientific Journals
19
Abstracts Presented at
Scientific Meetings
We make significant contributions to pivotal studies which drive evidence-based decision-making and optimization of outcomes.
Through a commitment to diversity and inclusivity, Dermatology Research Institute boasts personnel with different backgrounds and perspectives leading to increased creativity, more powerful innovation, faster problem-solving, and greater empathy.
Collectively, Our 15 Staff → Born in 5 Different Countries, Speak 6 Different Languages, Completed Studies in 6 Different Countries
We respect all people, irrespective of age, gender, sexual orientation, race, ethnicity, culture, religion, socioeconomic status, and ability.
